NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

By M. Daly, R. Pilarski, Michael P. Berry, S. Buys, Meagan B. Farmer, S. Friedman, J. Garber, N. Kauff, S. Khan, Catherine Klein and 17 more. The Journal of the National Comprehensive Cancer Network, 2017

608 citations recorded by the source corpus.

Subfields: Genetics

View Paper: https://www.semanticscholar.org/paper/6b25d993085f04ac4028c426b193af63e9fb429f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Lindsey A. Torre
2. A. Jemal
3. R. Siegel

Citations in the corpus

• Ovarian Cancer Statistics, 2018 (2018, background): “The National Comprehensive Cancer Network also recommends consideration of bilateral salpingo-oophorectomy for women ages 45 to 50 years who are carriers of BRIP1, RAD51C, and RAD51D mutations.(68) The American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncology sugges”